Quanterix Corporation
QTRX
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researcā¦ read more
Healthcare
Medical Devices
8 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$6.41
Price+0.85%
$0.05
1Y
Price
Market Cap
$299.608m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-78.2%
EBITDA Margin-83.5%
Net Profit Margin-104.4%
Free Cash Flow Margin-78.2%
EBITDA Margin-83.5%
Net Profit Margin-104.4%
Free Cash Flow MarginRevenue
$128.983m
-4.8%
1y CAGR+7.3%
3y CAGR+4.3%
5y CAGREarnings
-$95.662m
-148.3%
1y CAGR-37.5%
3y CAGR-48.0%
5y CAGREPS
-$2.33
-133.0%
1y CAGR-27.4%
3y CAGR-36.3%
5y CAGRBook Value
$314.534m
$444.140m
Assets$129.606m
Liabilities$40.120m
DebtDebt to Assets
9.0%
-0.4x
Debt to EBITDAFree Cash Flow
-$68.216m
-77.0%
1y CAGR-28.2%
3y CAGR-20.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company